P. Rossing, Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005, Diabetologia, vol.1, issue.1, pp.11-20, 2005.
DOI : 10.1093/ajh/1.4.335

D. Hertzberg, U. Sartipy, and M. Holzmann, Type 1 and type 2 diabetes mellitus and risk of acute kidney injury after coronary artery bypass grafting, American Heart Journal, vol.170, issue.5, pp.895-902, 2015.
DOI : 10.1016/j.ahj.2015.08.013

Y. Takiyama, M. Haneda, L. Chawla, and P. Kimmel, Hypoxia in diabetic kidneys Acute kidney injury and chronic kidney disease: an integrated clinical syndrome, Biomed Res Int Kidney Int, vol.201482, issue.5, pp.837421516-837421540, 2012.

Y. Goor, G. Peer, A. Iaina, M. Blum, Y. Wollman et al., Nitric oxide in ischaemic acute renal failure of streptozotocin diabetic rats, Diabetologia, vol.103, issue.Suppl 4, pp.1036-1076, 1996.
DOI : 10.1007/BF00169160

R. Podrazik, J. Natale, G. Zelenock, D. Alecy, and L. , Hyperglycemia exacerbates and insulin fails to protect in acute renal ischemia in the rat, Journal of Surgical Research, vol.46, issue.6, pp.572-580, 1989.
DOI : 10.1016/0022-4804(89)90022-X

K. Kelly, J. Burford, and J. Dominguez, Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy, AJP: Renal Physiology, vol.297, issue.4, pp.923-954, 2009.
DOI : 10.1152/ajprenal.00205.2009

A. Molofsky, A. Savage, and R. Locksley, Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation, Immunity, vol.42, issue.6, pp.1005-1024, 2015.
DOI : 10.1016/j.immuni.2015.06.006
URL : https://doi.org/10.1016/j.immuni.2015.06.006

F. Liew, J. Girard, and H. Turnquist, Interleukin-33 in health and disease, Nature Reviews Immunology, vol.2013, issue.11, pp.676-89, 2016.
DOI : 10.1186/ar4143

A. Akcay, Q. Nguyen, Z. He, K. Turkmen, W. Lee et al., IL-33 Exacerbates Acute Kidney Injury, Journal of the American Society of Nephrology, vol.22, issue.11, pp.2057-67, 2011.
DOI : 10.1681/ASN.2010091011
URL : http://jasn.asnjournals.org/content/22/11/2057.full.pdf

H. Jang and H. Rabb, Immune cells in experimental acute kidney injury, Nature Reviews Nephrology, vol.282, issue.2, pp.88-101, 2015.
DOI : 10.1016/j.clim.2008.08.016

M. Townsend, P. Fallon, D. Matthews, H. Jolin, and A. Mckenzie, T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses, The Journal of Experimental Medicine, vol.151, issue.6, pp.1069-76, 2000.
DOI : 10.1074/jbc.271.10.5784

J. Goujon, T. Hauet, E. Menet, P. Levillain, P. Babin et al., Histological Evaluation of Proximal Tubule Cell Injury in Isolated Perfused Pig Kidneys Exposed to Cold Ischemia, Journal of Surgical Research, vol.82, issue.2, pp.228-261, 1999.
DOI : 10.1006/jsre.1998.5526

D. Onk, O. Onk, K. Turkmen, H. Erol, T. Ayazoglu et al., Melatonin Attenuates Contrast-Induced Nephropathy in Diabetic Rats: The Role of Interleukin-33 and Oxidative Stress, Mediators of Inflammation, vol.153, issue.6, p.9050828, 2016.
DOI : 10.1023/a:1010968611716

C. Stehouwer, M. Gall, J. Twisk, E. Knudsen, J. Emeis et al., Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes: Progressive, Interrelated, and Independently Associated With Risk of Death, Diabetes, vol.51, issue.4, pp.1157-65, 2002.
DOI : 10.2337/diabetes.51.4.1157

A. Caporali, M. Meloni, A. Miller, K. Vierlinger, A. Cardinali et al., Soluble ST2 Is Regulated by p75 Neurotrophin Receptor and Predicts Mortality in Diabetic Patients With Critical Limb Ischemia, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.12, pp.149-60, 2012.
DOI : 10.1161/ATVBAHA.112.300497

E. Coglianese, M. Larson, R. Vasan, J. Ho, A. Ghorbani et al., Distribution and Clinical Correlates of the Interleukin Receptor Family Member Soluble ST2 in the Framingham Heart Study, Clinical Chemistry, vol.58, issue.12, pp.1673-81, 2012.
DOI : 10.1373/clinchem.2012.192153

M. Lopes-virella, R. Carter, G. Gilbert, R. Klein, M. Jaffa et al., Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications, Diabetes Care, vol.31, issue.10, pp.2006-2018, 2008.
DOI : 10.2337/dc08-0659

D. Nguyen, L. Shaw, and M. Grant, Inflammation in the pathogenesis of microvascular complications in diabetes, Frontiers in Endocrinology, vol.3, p.170, 2012.
DOI : 10.3389/fendo.2012.00170

D. Li, R. Guabiraba, A. Besnard, M. Komai-koma, M. Jabir et al., IL-33 promotes ST2-dependent lung fibrosis by the induction??of alternatively activated macrophages and innate??lymphoid cells in mice, Journal of Allergy and Clinical Immunology, vol.134, issue.6, pp.1422-1454, 2014.
DOI : 10.1016/j.jaci.2014.05.011

Y. Choi, H. Choi, J. Min, B. Pyun, Y. Maeng et al., Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production, Blood, vol.114, issue.14, pp.3117-3143, 2009.
DOI : 10.1182/blood-2009-02-203372
URL : http://www.bloodjournal.org/content/bloodjournal/114/14/3117.full.pdf

M. Monseu, E. Gand, P. Saulnier, S. Ragot, X. Piguel et al., Acute Kidney Injury Predicts Major Adverse Outcomes in Diabetes: Synergic Impact With Low Glomerular Filtration Rate and Albuminuria, Diabetes Care, vol.38, issue.12, pp.2333-2373, 2015.
DOI : 10.2337/dc15-1222